Hertwig's anemia: characterization of the stem cell defect

Area of Science:

• Hematology
• Stem Cell Biology
• Genetics

Background:

• Hertwig's anemia (an/an) in mice presents as a mild macrocytic anemia.
• Affected mice are refractory to erythropoietin (EP) treatment, with decreased red and white blood cell counts.
• A potential cause is a reduced precursor stem cell population.

Purpose of the Study:

• To investigate the hypothesis of a depleted precursor stem cell population in Hertwig's anemia.
• To compare stem cell factor (SCF) and erythropoietin (EP)-responsive progenitor numbers in an/an and wild-type mice.
• To assess the in vitro response of erythroid-committed stem cells to EP.

Main Methods:

• Quantification of Colony-Forming Unit-Spleen (CFU-S), Burst-Forming Unit-Erythroid (BFU-E), and Colony-Forming Unit-Erythroid (CFU-E) in bone marrow of an/an and +/+ mice.
• In vitro assessment of erythroid-committed stem cell responsiveness to erythropoietin (EP).

Main Results:

• Mice with Hertwig's anemia exhibit significantly reduced numbers of both BFU-E and CFU-E.
• Erythroid-committed stem cells are more severely impacted than their earlier progenitors, the CFU-S.
• The data indicate that erythropoietin (EP) resistance is due to diminished cell numbers, not decreased EP sensitivity.

Conclusions:

• Hertwig's anemia is characterized by a reduction in erythroid-committed stem and progenitor cells.
• Cell loss occurs during the progressive differentiation from stem cell to mature erythrocyte in an/an mice.
• The findings highlight a quantitative defect in hematopoietic stem cells contributing to anemia and EP resistance.